Prudential Financial’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.6M | Buy |
15,875
+9,938
| +167% | +$1.53M | ﹤0.01% | 1210 |
|
|
2025
Q4 | $1.03M | Sell |
5,937
-5,033
| -46% | -$918K | ﹤0.01% | 1586 |
|
|
2025
Q3 | $1.58M | Sell |
10,970
-144,470
| -93% | -$17.7M | ﹤0.01% | 1471 |
|
|
2025
Q2 | $15.6M | Buy |
155,440
+263
| +0.2% | +$20.1K | 0.02% | 491 |
|
|
2025
Q1 | $11.8M | Buy |
155,177
+8,455
| +6% | +$647K | 0.02% | 534 |
|
|
2024
Q4 | $10.1M | Buy |
146,722
+12,132
| +9% | +$874K | 0.01% | 608 |
|
|
2024
Q3 | $9.83M | Buy |
134,590
+78,496
| +140% | +$5.79M | 0.01% | 691 |
|
|
2024
Q2 | $3.76M | Buy |
56,094
+45,657
| +437% | +$1.77M | 0.01% | 1051 |
|
|
2024
Q1 | $283K | Sell |
10,437
-2,083
| -17% | -$58.3K | ﹤0.01% | 2358 |
|
|
2023
Q4 | $388K | Buy |
12,520
+698
| +6% | +$18.1K | ﹤0.01% | 2236 |
|
|
2023
Q3 | $299K | Buy |
11,822
+118
| +1% | +$2.7K | ﹤0.01% | 2264 |
|
|
2023
Q2 | $247K | Sell |
11,704
-51,279
| -81% | -$973K | ﹤0.01% | 2364 |
|
|
2023
Q1 | $1.07M | Sell |
62,983
-162,823
| -72% | -$3.16M | ﹤0.01% | 1711 |
|
|
2022
Q4 | $4.51M | Sell |
225,806
-104,853
| -32% | -$2.03M | 0.01% | 910 |
|
|
2022
Q3 | $7.12M | Buy |
330,659
+319,714
| +2,921% | +$7.67M | 0.01% | 757 |
|
|
2022
Q2 | $219K | Sell |
10,945
-13
| -0.1% | -$272 | ﹤0.01% | 2440 |
|
|
2022
Q1 | $257K | Buy |
10,958
+103
| +0.9% | +$2.39K | ﹤0.01% | 2455 |
|
|
2021
Q4 | $363K | Sell |
10,855
-611
| -5% | -$17.5K | ﹤0.01% | 2324 |
|
|
2021
Q3 | $307K | Buy |
11,466
+1,344
| +13% | +$35.3K | ﹤0.01% | 2307 |
|
|
2021
Q2 | $288K | Sell |
10,122
-58,526
| -85% | -$1.74M | ﹤0.01% | 2326 |
|
|
2021
Q1 | $2.34M | Sell |
68,648
-15,868
| -19% | -$606K | ﹤0.01% | 1376 |
|
|
2020
Q4 | $2.81M | Buy |
84,516
+34,588
| +69% | +$1.26M | ﹤0.01% | 1264 |
|
|
2020
Q3 | $1.6M | Buy |
49,928
+26,127
| +110% | +$751K | ﹤0.01% | 1425 |
|
|
2020
Q2 | $655K | Buy |
23,801
+7,862
| +49% | +$186K | ﹤0.01% | 1818 |
|
|
2020
Q1 | $255K | Buy |
+15,939
| New | +$378K | ﹤0.01% | 2113 |
|
|
2019
Q3 | – | Sell |
-8,137
| Closed | -$208K | – | 2441 |
|
|
2019
Q2 | $208K | Sell |
8,137
-26,403
| -76% | -$735K | ﹤0.01% | 2329 |
|
|
2019
Q1 | $1M | Buy |
+34,540
| New | +$895K | ﹤0.01% | 1877 |
|
|
2018
Q1 | – | Sell |
-7,320
| Closed | -$228K | – | 2373 |
|
|
2017
Q4 | $228K | Sell |
7,320
-120
| -2% | -$3.54K | ﹤0.01% | 2224 |
|
|
2017
Q3 | $232K | Buy |
+7,440
| New | +$142K | ﹤0.01% | 2223 |
|
Other funds holding INSM
DGM
VPM
VCM
BBA
Prudential Financial's INSM Position: Q1 2026 in Review
Prudential Financial increased its Insmed (INSM) stake by 167% in Q1 2026, buying an estimated $1.53M and bringing the position to 15,875 shares worth $2.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1210.
Prudential Financial first reported a position in INSM in Q3 2017 and has held it in 29 quarters since. The position peaked at $15.6M in Q2 2025. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.
- Prudential Financial held 15,875 shares of Insmed worth $2.6M as of Q1 2026.
- Prudential Financial bought 9,938 Insmed shares in Q1 2026, an estimated $1.53M.
- Insmed made up ﹤0.01% of Prudential Financial's portfolio in Q1 2026, its #1210 holding.
- Prudential Financial first reported a position in Insmed in Q3 2017 and has held it in 29 quarters since.
- Prudential Financial's Insmed position peaked at $15.6M in Q2 2025.
- 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.
Based on Prudential Financial's 13F filing for Q1 2026, filed 13 May 2026.